NCT07491185

Brief Summary

This prospective observational study aims to evaluate the effect of glycemic control level on intraoperative cerebral oxygenation measured by near-infrared spectroscopy (NIRS) and postoperative recovery in patients with diabetes mellitus undergoing elective urologic surgery under general anesthesia. Patients will be grouped according to HbA1c levels to assess the relationship between long-term glycemic control and intraoperative regional cerebral oxygen saturation, hemodynamic parameters, and postoperative recovery scores.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Nov 2025Mar 2027

Study Start

First participant enrolled

November 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 24, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

March 18, 2026

Last Update Submit

March 18, 2026

Conditions

Keywords

Diabetes MellitusGlycemic ControlNear-Infrared SpectroscopyPostoperative Recovery

Outcome Measures

Primary Outcomes (1)

  • Change in Regional Cerebral Oxygen Saturation (rSO2)

    Regional cerebral oxygen saturation measured intraoperatively using near-infrared spectroscopy and compared between groups according to HbA1c level.

    Intraoperative period (from anesthesia induction to extubation)

Study Arms (4)

Control

Non-diabetic patients

HbA1c 6-7

Diabetic patients with HbA1c between 6% and 7%

HbA1c 7-8

Diabetic patients with HbA1c between 7% and 8%

HbA1c >8

Diabetic patients with HbA1c greater than 8%

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients scheduled for elective urologic surgery under general anesthesia at a single tertiary university hospital will be included. The study population consists of patients with diabetes mellitus with different levels of glycemic control and non-diabetic control patients. Participants will be grouped according to preoperative HbA1c levels.

You may qualify if:

  • Age ≥18 years
  • Patients scheduled for elective urologic surgery under general anesthesia
  • ASA physical status I-III
  • Patients with diabetes mellitus or non-diabetic control patients
  • Availability of preoperative HbA1c measurement
  • Written informed consent obtained

You may not qualify if:

  • Age \<18 years
  • ASA physical status \>III
  • Emergency surgery
  • History of cerebrovascular disease or neurological disorder
  • Previous brain or neurological surgery
  • Inability to communicate or refusal to participate
  • Intraoperative hemodynamic instability
  • Inadequate NIRS monitoring data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University Faculty of Medicine Hospital

Izmir, 35100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • NURSEN KARACA, MD

    Ege University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Işık Alper, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 18, 2026

First Posted

March 24, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

March 24, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to institutional regulations and privacy restrictions.

Locations